Urothelial cancer (UC) is the most common histology seen in bladder tumors. The 2022 WHO classification of urinary tract tumors includes a list of less common subtypes (formerly known as variants) for ...

Men with overactive bladder had significant 95% reduced odds of urinary tract cancers compared with a reference group of men with urolithiasis, after adjusting for age. Overactive bladder (OAB) is ...

Adults with type 2 diabetes (T2D) who initiated empagliflozin treatment did not face a higher risk for urinary tract cancers (UTCs), such as bladder or renal cancer, than those who initiated DPP-4 ...

Disparate Rates of Germline Variants in Cancer Predisposition Genes in African American/Black Compared With Non-Hispanic White Individuals Between 2015 and 2022 Clinically actionable germline PVs in ...

Bladder cancer affects approximately 83,000 Americans each year, yet remains one of the most overlooked forms of cancer despite having excellent survival rates when caught early. This disconnect ...

Pharmaceutical treatment for urinary tract infections (UTI) is significantly associated with a higher risk for a delayed diagnosis of muscle-invasive or metastatic bladder cancer. Treatment for ...

Urinary tract infections (UTIs) commonly occur in people who undergo chemotherapy. The treatment can weaken the immune system and damage barriers, such as the skin and mucous membranes, that help ...

Various studies show that 30-40 percent of people with bladder cancer report symptoms or diagnosis of urinary tract infection in the year before a diagnosis of bladder cancer.

Cancer cell-derived small extracellular vesicles (sEVs) can travel from distant tumors through the bloodstream and kidneys ...